Active Biotech AB | Cash Flow

Fiscal year is January-December. All values SEK Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
214,294.00
233,720.00
184,739.00
61,792.00
109,897.00
36,878
Depreciation, Depletion & Amortization
12,898.00
12,257.00
9,188.00
8,910.00
6,134.00
447
Other Funds
-
-
2,857.00
2,858.00
50,455.00
-
Funds from Operations
201,396.00
221,463.00
172,694.00
50,024.00
53,308.00
36,431
Changes in Working Capital
99,146.00
45,627.00
45,193.00
23,139.00
6,861.00
4,216
Net Operating Cash Flow
102,250.00
267,090.00
217,887.00
73,163.00
46,447.00
40,647
Capital Expenditures
53.00
1,901.00
-
-
-
Net Investing Cash Flow
53.00
1,901.00
-
-
-
Issuance/Reduction of Debt, Net
7,914.00
2,328.00
6,951.00
6,484.00
6,078.00
Net Financing Cash Flow
261,837.00
221,251.00
6,951.00
47,223.00
6,078.00
Net Change in Cash
159,534.00
47,740.00
224,838.00
25,940.00
52,525.00
Free Cash Flow
102,303.00
268,991.00
-
73,163.00
46,447.00
Change in Capital Stock
269,751.00
223,579.00
-
53,707.00
-

About Active Biotech AB

View Profile
Address
Scheelevägen 22
Lund SN 223 63
Sweden
Employees -
Website http://www.activebiotech.com
Updated 07/08/2019
Active Biotech AB develops pharmaceutical preparations. It develops pharmaceutical products within medical areas where the immune defense is of significant importance, including neurodegenerative diseases, autoimmune, inflammatory disease and various forms of cancer. The company's project portfolio comprises small, orally active immunomodulatory molecules as well as antibody-based immunotherapy.